Table 2.
Summary of meta-analysis results of non-modifiable factors for mortality in non-HIV-related Pneumocystis pneumonia.
| Factors | No. study | Sample (n) | Heterogeneity test | Effects model | OR/MD (95% CI) | P-value | |
|---|---|---|---|---|---|---|---|
| P-value | I2 (%) | ||||||
| Age | 14 | 990 | 0.24 | 20 | Fixed effects model | 6.61 (4.48–8.74) | <0.00001 |
| Sex | 13 | 948 | 0.21 | 23 | Fixed effects model | 1.02 (0.77–1.35) | 0.9 |
| Concomitant with other pulmonary diseases at diagnosis of PCP | 6 | 477 | 0.52 | 0 | Fixed effects model | 3.42 (1.96–5.96) | <0.0001 |
| Solid tumors | 6 | 534 | 0.46 | 0 | Fixed effects model | 2.06 (1.32–3.21) | 0.002 |
CI, confidence interval; MD, mean difference; OR, odds ratio.